Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.
Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment
PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38
Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf–Mdm2–p53 and RP–Mdm2–p53 pathways
Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer
CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro
Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer
ATM-mediated KDM2A phosphorylation is required for the DNA damage repair
Lineage factors and differentiation states in lung cancer progression
Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein
Cancer whole-genome sequencing: present and future
Send Us Feedback
Are we missing a journal?
Would you like to see changes on these pages?
email us your feedback...
Event Support and Materials
Pipelines in Oncology
The Cancer Letter
Maps, Directions, and Shuttles